Announced Mon, 6 Apr · 19:03 IST
No NCD payment obligations for Q1 2026 - Reg 57(5) intimation
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹27.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.0-0.0+0.4+5.5+13.0+13.7+18.5+11.7+5.9+4.4
Up moveDown movePending
AI summary
Prism Medico and Pharmacy Ltd filed a SEBI Regulation 57(5) intimation confirming it has not issued any non-convertible securities. As a result, no interest, dividend, or principal payments were due during Q1 2026 (Jan 1 to Mar 31, 2026). This is a routine quarterly compliance disclosure with no material financial event.
Likely market impact
Routine compliance filing; no financial impact. Confirms the company has no NCD-related payment obligations for the quarter.